NDC 51662-1564

ZIPRASIDONE MESYLATE

Ziprasidone Mesylate

ZIPRASIDONE MESYLATE is a Intramuscular Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Ziprasidone Mesylate.

Product ID51662-1564_c75971f8-9641-a6e8-e053-2995a90af654
NDC51662-1564
Product TypeHuman Prescription Drug
Proprietary NameZIPRASIDONE MESYLATE
Generic NameZiprasidone Mesylate
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAMUSCULAR
Marketing Start Date2021-07-17
Marketing CategoryANDA /
Application NumberANDA211908
Labeler NameHF Acquisition Co LLC, DBA HealthFirst
Substance NameZIPRASIDONE MESYLATE
Active Ingredient Strength20 mg/mL
Pharm ClassesAtypical Antipsychotic [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 51662-1564-3

10 POUCH in 1 CASE (51662-1564-3) > 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1564-2) > 5 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2021-07-17
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "ZIPRASIDONE MESYLATE" or generic name "Ziprasidone Mesylate"

NDCBrand NameGeneric Name
43598-848ziprasidone mesylateziprasidone mesylate
51662-1564ZIPRASIDONE MESYLATEZIPRASIDONE MESYLATE
68083-340ziprasidone mesylateziprasidone mesylate
72266-160ziprasidone mesylateziprasidone mesylate
0049-1203Geodonziprasidone mesylate
0049-3920Geodonziprasidone mesylate
50090-4540Geodonziprasidone mesylate
64725-3920Geodonziprasidone mesylate

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.